Free Trial

Pharma-Bio Serv Q2 2024 Earnings Report

Pharma-Bio Serv logo
$0.50 +0.07 (+16.28%)
As of 03/31/2025 03:52 PM Eastern

Pharma-Bio Serv EPS Results

Actual EPS
-$0.01
Consensus EPS
$0.03
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A

Pharma-Bio Serv Revenue Results

Actual Revenue
$2.38 million
Expected Revenue
$3.00 million
Beat/Miss
Missed by -$620.00 thousand
YoY Revenue Growth
N/A

Pharma-Bio Serv Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

Pharma-Bio Serv Earnings Headlines

Zacks Small Cap Cuts Earnings Estimates for Pharma-Bio Serv
PBSV Returns to Growth
New “Trump” currency proposed in DC
After a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out first. Warren Buffett sold off 115 million shares of Apple last year.
See More Pharma-Bio Serv Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pharma-Bio Serv? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your email.

About Pharma-Bio Serv

Pharma-Bio Serv (OTCMKTS:PBSV) operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

View Pharma-Bio Serv Profile

More Earnings Resources from MarketBeat